Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antigenic sites on foot-and-mouth disease virus type A10.

Literature DB >> 2455819

Antigenic sites on foot-and-mouth disease virus type A10.

A A Thomas¹, R J Woortmeijer, W Puijk, S J Barteling.

Abstract

A set of monoclonal antibodies was used to isolate nonneutralizable foot-and-mouth disease virus variants, and the RNAs of the variants were sequenced. Cross-neutralization studies and mapping of the amino acid changes indicated two major antigenic sites. The first site was trypsin sensitive and included the VP1 140 to 160 sequence. The second site was trypsin insensitive and included mainly VP3 residues. Two minor sites were located near VP1 169 and on the C terminus of VP1. Comparison with poliovirus type 1 and human rhinovirus 14 showed a similarity in the immunogenicity of comparable sites on the viruses.

Entities: Disease Species

Mesh：

Substances：

Year: 1988 PMID： 2455819 PMCID： PMC253712

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

28 in total

1. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.

Authors: Q C Xie; D McCahon; J R Crowther; G J Belsham; K C McCullough
Journal: J Gen Virol Date: 1987-06 Impact factor: 3.891

2. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.

Authors: R H Meloen; W C Puyk; D J Meijer; H Lankhof; W P Posthumus; W M Schaaper
Journal: J Gen Virol Date: 1987-02 Impact factor: 3.891

3. A priori delineation of a peptide which mimics a discontinuous antigenic determinant.

Authors: H M Geysen; S J Rodda; T J Mason
Journal: Mol Immunol Date: 1986-07 Impact factor: 4.407

4. Antigenic structure of polioviruses of serotypes 1, 2 and 3.

Authors: P D Minor; M Ferguson; D M Evans; J W Almond; J P Icenogle
Journal: J Gen Virol Date: 1986-07 Impact factor: 3.891

5. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination.

Authors: E Beck; K Strohmaier
Journal: J Virol Date: 1987-05 Impact factor: 5.103

6. Three-dimensional structure of poliovirus at 2.9 A resolution.

Authors: J M Hogle; M Chow; D J Filman
Journal: Science Date: 1985-09-27 Impact factor: 47.728

7. Protection of cattle against foot-and-mouth disease by a synthetic peptide.

Authors: R DiMarchi; G Brooke; C Gale; V Cracknell; T Doel; N Mowat
Journal: Science Date: 1986-05-02 Impact factor: 47.728

8. The atomic structure of Mengo virus at 3.0 A resolution.

Authors: M Luo; G Vriend; G Kamer; I Minor; E Arnold; M G Rossmann; U Boege; D G Scraba; G M Duke; A C Palmenberg
Journal: Science Date: 1987-01-09 Impact factor: 47.728

9. Surface structure and RNA-protein interactions of foot-and-mouth disease virus.

Authors: D J Morrell; E J Mellor; D J Rowlands; F Brown
Journal: J Gen Virol Date: 1987-06 Impact factor: 3.891

10. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14.

Authors: B Sherry; A G Mosser; R J Colonno; R R Rueckert
Journal: J Virol Date: 1986-01 Impact factor: 5.103

57 in total

Review 1. Foot-and-mouth disease.

Authors: Marvin J Grubman; Barry Baxt
Journal: Clin Microbiol Rev Date: 2004-04 Impact factor: 26.132

2. Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.

Authors: J C Saiz; M J Gonzalez; M V Borca; F Sobrino; D M Moore
Journal: J Virol Date: 1991-05 Impact factor: 5.103

10. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.

Authors: M G Mateu; J Hernández; M A Martínez; D Feigelstock; S Lea; J J Pérez; E Giralt; D Stuart; E L Palma; E Domingo
Journal: J Virol Date: 1994-03 Impact factor: 5.103

Antigenic sites on foot-and-mouth disease virus type A10.

1. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.

2. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.

3. A priori delineation of a peptide which mimics a discontinuous antigenic determinant.

4. Antigenic structure of polioviruses of serotypes 1, 2 and 3.

5. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination.

6. Three-dimensional structure of poliovirus at 2.9 A resolution.

7. Protection of cattle against foot-and-mouth disease by a synthetic peptide.

8. The atomic structure of Mengo virus at 3.0 A resolution.

9. Surface structure and RNA-protein interactions of foot-and-mouth disease virus.

10. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14.

Review 1. Foot-and-mouth disease.

2. Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.

3. Expression of foreign epitopes in P-fimbriae of Escherichia coli.

4. Nucleotide sequence of the P1 region of foot-and-mouth disease virus strain O1 Caseros.

5. Antigenic stability of foot-and-mouth disease virus variants on serial passage in cell culture.

6. Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus.

7. Hyper-antigenic variation occurs with human rhinovirus type 17.

Review 8. Development of foot-and-mouth disease virus strain characterisation--a review.

9. Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus.

10. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.